Cellular Senescence Mediates Doxorubicin Chemotherapy-Induced Vascular Endothelial Dysfunction: Translational Evidence of Prevention with Senolytic Treatment
Ravinandan Venkatasubramanian, Sophia A. Mahoney, David A. Hutton, Nicholas S. VanDongen, Vienna Elizabeth Brunt, Nathan Greenberg, Abigail G. Longtine, Lukas Brandt, Andreas Beyer, Simon Melov, Judith Campisi, Matthew J. Rossman, Douglas R. Seals, Zachary Stephen Clayton
This study shows that cellular senescence contributes to Doxorubicin-induced vascular endothelial dysfunction and that senolytic treatment can prevent this dysfunction.
American Journal of Physiology-Heart and Circulatory Physiology · Oct 27, 2025Peer-reviewedPhysiology